title: Acute Fatty Liver of Pregnancy: Analysis on the Diagnosis and Treatment of 15 Cases.
abstract: OBJECTIVE
  To describe our experience with the diagnosis and management of acute fatty liver of pregnancy (AFLP).
  
  
  METHODS
  The medical records of pregnant women with AFLP were reviewed for symptoms, laboratory findings, treatment, and maternal and fetal outcomes during a 10-year period between January 2003 and December 2013.
  
  
  RESULTS
  During the study period 15 women had AFLP as their discharge diagnosis. The mean gestational age at onset was 36 ± 1 weeks. Eleven cases were primigravidas, and 2 had multiple gestations. All patients presented with nausea, vomiting, and epigastric distress followed by jaundice in the third trimester of pregnancy. Raised transaminases and serum bilirubin as well as coagulopathy were found in all patients (100%), while hypoglycemia was found in 8 patients (53%). Ultrasound examination showed enhanced echo or fatty liver in 11 patients. Maternal morbidity included hepatic encephalopathy (n = 1), renal failure (n = 3), ascites (n = 6), hypoglycemia (n = 8), postpartum hemorrhage (n = 6), upper gastrointestinal hemorrhage (n = 1), and preeclampsia (n = 1). Emergency cesarean section was performed in 12 cases and supracervical hysterectomy was performed in 1 patient due to postpartum hemorrhage and disseminated intravascular coagulation (DIC); all patients survived. All neonates survived except for 2 fetal death cases before admission.
  
  
  CONCLUSIONS
  Early diagnosis and prompt progressive management, including early termination of pregnancy and comprehensive supportive care, are crucial for improving the prognoses of both mother and newborn.
authors.forename: Guoyan
authors.initials: G
authors.lastname: Liu
authors.forename: Xiaobin
authors.initials: X
authors.lastname: Shang
authors.forename: Bibo
authors.initials: B
authors.lastname: Yuan
authors.forename: Cha
authors.initials: C
authors.lastname: Han
authors.forename: Yingmei
authors.initials: Y
authors.lastname: Wang
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001201:Ascites / Q000209:etiology; D001778:Blood Coagulation Disorders / Q000209:etiology; D001803:Blood Transfusion; D002585:Cesarean Section; D036861:Delivery, Obstetric; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D042241:Early Diagnosis; D061345:Early Medical Intervention; D005234:Fatty Liver / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D005260:Female; D005313:Fetal Death; D005440:Fluid Therapy; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D005865:Gestational Age; D020073:Gravidity; D006501:Hepatic Encephalopathy / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009325:Nausea / Q000209:etiology; D011181:Postnatal Care; D006473:Postpartum Hemorrhage / Q000209:etiology; D011225:Pre-Eclampsia / Q000209:etiology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000628:therapy*; D011263:Pregnancy Trimester, Third; D011272:Pregnancy, Multiple; D011379:Prognosis; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000959:Antihypertensive Agents